← Eichor
Study identifier: NCT07055191 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

TOETVA Technique Compared With Anterior Cervical Thyroidectomy (AC) in Terms of Efficacy and Safety

Condition: Lobectomy · Thyroidectomy  ·  Sponsor: University Hospital, Lille

PhaseNA
Planned participants616
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Nearly 50,000 thyroidectomies are performed in France each year for benign and malignant pathologies. Each one affects the life of the patient and represents, for some, suffering, symbolized by the stigma of the operation. The consequences of these scars vary according to the patient, their experience and their culture. For example, cervicotomies are particularly badly accepted in Asia since they are supposed to interrupt the fertility meridian. In France, increasing attention is being paid to the global management of a person with some disease. As a disease state may be transitory, the medical team must consider the situation "after the illness" and plan a return to normality. In particular, alternative approaches to cervicotomy have been developed, in which the scar is in a less visible location, at the cost of a more extensive dissection. These techniques include the transaxillary approach, the bi-areolar biaxillary approach and the retroauricular approach. Such procedures, initially developed as an endoscopic approach, have become progressively robotically assisted, to help with the ergonomics of the procedure. Even though robotic assistance initially helped to spread use of these techniques, it has, over time, limited them, first because of higher cost, and second because of the high learning curve (50 to 75 cases). Finally, the transaxillary approach, which is the most commonly performed, has an inherent problem due to the decreased visibility of the noble structures on…

This description comes directly from the study's public registry record.

Talk to the study team

Robert Caiazzo, Prof.  ·  +33 (0)3 20 44 55 15  ·  robert.caiazzo@chu-lille.fr

Always discuss trial participation with your own doctor first.

Locations (10)

AP-HP - Hôpital AvicennesBobigny, FranceNot Yet Recruiting
Hôpital Franco-BritanniqueLevallois-Perret, FranceNot Yet Recruiting
CHU de Lille, Hôpital HuriezLille, FranceRecruiting
CHU DupuytrenLimoges, FranceNot Yet Recruiting
CHU de Nantes - Hôtel DieuNantes, FranceNot Yet Recruiting
AP-HP - Hôpital CochinParis, FranceNot Yet Recruiting
Hôpital Lyon SudPierre-Bénite, FranceNot Yet Recruiting
CHU de PoitiersPoitiers, FranceNot Yet Recruiting
Polyclinique de la Côte Basque SudSaint-Jean-de-Luz, FranceNot Yet Recruiting
CHRU de Nancy BraboisVandœuvre-lès-Nancy, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07055191